Literature DB >> 17906217

Barriers to effective TRAIL-targeted therapy of malignancy.

Martin J S Dyer, Marion MacFarlane, Gerald M Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17906217     DOI： 10.1200/JCO.2007.13.1011

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  32 in total

1.  TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.

Authors:  Gaëlle Picarda; Valérie Trichet; Stéphane Téletchéa; Dominique Heymann; Françoise Rédini
Journal:  Am J Cancer Res       Date:  2011-10-09       Impact factor: 6.166

2.  Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy.

Authors:  Alaa Refaat; Sherif Abdelhamed; Ikuo Saiki; Hiroaki Sakurai
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

3.  Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.

Authors:  L O'Leary; A M van der Sloot; C R Reis; S Deegan; A E Ryan; S P S Dhami; L S Murillo; R H Cool; P Correa de Sampaio; K Thompson; G Murphy; W J Quax; L Serrano; A Samali; E Szegezdi
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

4.  Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors.

Authors:  Bokyung Sung; Byoungduck Park; Vivek R Yadav; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

5.  Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.

Authors:  Seong Muk Kim; Ji Sun Woo; Chang Hyun Jeong; Chung Heon Ryu; Jae-Deog Jang; Sin-Soo Jeun
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

Review 6.  TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.

Authors:  Peter A Holoch; Thomas S Griffith
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

7.  Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.

Authors:  Ji-Young Jang; Yoon-Kyung Jeon; Yun Choi; Chul-Woo Kim
Journal:  Mol Cancer       Date:  2010-09-28       Impact factor: 27.401

8.  Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model.

Authors:  Qiang Chen; Lei Chen; Ren Zhao; Xiao-dong Yang; Khan Imran; Chun-gen Xing
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-07       Impact factor: 4.553

9.  Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: role for ATP-sensitive K+ channels and endoplasmic reticulum stress.

Authors:  Yoshihiro Suzuki; Toshio Inoue; Mayumi Murai; Miki Suzuki-Karasaki; Toyoko Ochiai; Chisei Ra
Journal:  Int J Oncol       Date:  2012-05-17       Impact factor: 5.650

10.  High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival.

Authors:  P Noble; M Vyas; A Al-Attar; S Durrant; J Scholefield; L Durrant
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.